Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues RYAAY Q1 2026 Earnings Wide EPS Miss Still Spurs Positive Market Reaction TCBX Q1 2026 Earnings EPS Beats Estimates by 363 as Net Interest Income Drives Performance ASTI Q1 2026 Earnings Largerthanexpected loss on no revenue stock rallies Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending SU Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Efficiency Gains